21 June 2018

High cholesterol levels are a health risk, because of the increased chances of cardiovascular diseases. But research shows that low cholesterol can also be harmful. Researchers from Radboud university medical center and their Australian and American colleagues discovered a new metabolic defect, producing very low cholesterol levels. This causes brain anomalies, developmental delay, epilepsy and typical facial deformities.

When physicians at the Wesley Hospital in Brisbane, Australia, studied the urinalysis of one of their patients, they discovered a different profile of the organic acids that they could not quite explain. Could it be possible that the profile was connected to the cause of the disorder? They decided to contact chemist Ron Wevers, who had developed a technique at Radboud university medical center (NMR spectroscopy) with which substances in the urine can be detected in great detail, even when the quantities are very small. 

Faltering enzyme

Wevers: “The combination of the substances we found indicated that there was something wrong with the cholesterol production. Cholesterol enters our system through the food we eat, but the body itself is also capable of producing it. Apparently something went wrong in that process. It turned out that the enzyme that converts farnesol into squalene was not working properly. The urine contained far too much of the first substance and far too little of the second substance. The enzyme squalene synthase is the driving force of this conversion, so that is where we had to look to locate the problem.”    

Genetic surprise

Wevers was able to locate a second family suffering from the same defect. A total of three patients were found at the time suffering from the same disorder. If the enzyme squalene synthase (SS) is indeed the culprit, then it should be possible to find mutations in the gene FDFT 1, which is the gene that codes for the SS. However, the genetic research caused the researchers to be surprised. Wevers: “We found mutations in one family that disturbed the effect of the enzyme, but we did not find those in the other family. That was a mystery that we were unable to solve for a long time.” 

The solving of the mystery

The mystery was solved at long last by the research group of Lisenka Vissers of the Department of Genetics. Vissers: “A mutation causing a malfunctioning protein can usually be found in the gene itself. But in the second family the mutation was located outside the gene, which was why it had not been found in earlier genetic studies. This mutation prevents the gene for SS, which in essence is perfectly alright, to be read. That explains why the enzyme squalene synthase does not work after all. Mystery solved.”   

Diagnostics

The researchers have used this knowledge to develop a test that will make it easier to find new patients in the currently used urinalyses.

Publication in The American Journal of Human Genetics: Squalene Synthase Deficiency: Clinical, Biochemical, and Molecular Characterization of a Defect in Cholesterol Biosynthesis.

Related news items


European Commission Initiative on Breast Cancer (ECIBC) Guidelines

13 August 2019

In Annals of internal medicine Mireille Broeders and colleagues from the ECIBC Guidelines Development Group described the methods used to develop person-centered evidence-based recommendations for screening and diagnosis of breast cancer.

read more

Circulation publication for exercise physiologists

13 August 2019

Thijs Eijsvogels and Vincent Aengevaeren showed that exercise-incuded elevations of troponin concentrations are predictive of major adverse cardiovascular events and mortality.

read more

DELA, Radboudumc and Games for Health start a new project to fight loneliness among elderly using games

12 August 2019

More than half of people aged 75 and over feel their selves lonely every now and then. A special collaboration between DELA, Radboudumc, and Games for Health will investigate whether joined gaming between elderly and young people can alleviate this social problem.

read more

Floris Schreuder received Dekker grant

6 August 2019

Floris Schreuder received one of the ten Dekker grants from the Dutch Heart Foundation (Hartstichting).

read more

A warm welcome for a new RIMLS colleague Nico Sommerdijk

5 August 2019

As of 1 August we welcome Nico Sommerdijk as our new colleague at the RIMLS. Nico will join the department of Biochemistry, with his research group “Biochemistry of Mineralized Tissues”.

read more

Bart Kiemeney finishes 1st in the Tour and raises thousands of euros

30 July 2019

With over €43,000 on the counter, Kiemeney can see the Tour de France as a great success.

read more